MPW
NVO

MASECO Private Wealth’s Novo Nordisk NVO Stock Holding History

MASECO Private Wealth’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.8K Buy
559
+88
+19% +$3.78K ﹤0.01% 198
2026
Q1 		$17.3K Sell
471
-103
-18% -$4.88K ﹤0.01% 202
2025
Q4 		$29.2K Buy
+574
New +$29.4K ﹤0.01% 221
2025
Q3 		– Sell
-570
Closed -$39.3K – 436
2025
Q2 		$39.3K Buy
+570
New +$38.8K ﹤0.01% 187

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

MASECO Private Wealth's NVO Position: Q2 2026 in Review

MASECO Private Wealth increased its Novo Nordisk (NVO) stake by 19% in Q2 2026, buying an estimated $3.78K and bringing the position to 559 shares worth $26.8K. The position accounts for ﹤0.01% of the portfolio, ranked #198.

MASECO Private Wealth first reported a position in NVO in Q2 2025 and has held it in 4 quarters since. The position peaked at $39.3K in Q2 2025. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • MASECO Private Wealth held 559 shares of Novo Nordisk worth $26.8K as of Q2 2026.
  • MASECO Private Wealth bought 88 Novo Nordisk shares in Q2 2026, an estimated $3.78K.
  • Novo Nordisk made up ﹤0.01% of MASECO Private Wealth's portfolio in Q2 2026, its #198 holding.
  • MASECO Private Wealth first reported a position in Novo Nordisk in Q2 2025 and has held it in 4 quarters since.
  • MASECO Private Wealth's Novo Nordisk position peaked at $39.3K in Q2 2025.
  • 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on MASECO Private Wealth's 13F filing for Q2 2026, filed 5 Aug 2026.